Patrick Geraghty
Overview
Explore the profile of Patrick Geraghty including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
1835
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Connor C, Renaghan E, Bennett A, Ferrer L, Damodaran R, Geraghty P, et al.
Phys Ther Sport
. 2025 Feb;
72:32-38.
PMID: 39908711
Objectives: To report hip adduction, abduction, and adduction:abduction strength ratio values in NCAA Division I American football players, and to compare strength values across position groups. Design: Cross-sectional study. Setting:...
2.
3.
Dabo A, Raghavan S, Ezegbunam W, Thankachen J, Evgrafov O, Majka S, et al.
Sci Rep
. 2024 Nov;
14(1):28012.
PMID: 39543165
Alveolar capillary barrier disruption induces local edema and inflammation that impairs pulmonary function and promotes alveolar destruction in COPD. This study aimed to determine how cigarette smoke modulated the serine-threonine...
4.
Park S, Ward R, Geraghty P, Garcia-Arcos I
FEBS Open Bio
. 2024 Jul;
14(9):1441-1454.
PMID: 38952051
Glucose is essential for energy metabolism, and its usage can determine other cellular functions, depending on the cell type. In some pathological conditions, cells are exposed to high concentrations of...
5.
Gogoi D, Yu H, Casey M, Baird R, Yusuf A, Forde L, et al.
Thorax
. 2024 Feb;
79(9):822-833.
PMID: 38418195
Introduction: Altered complement component 3 (C3) activation in patients with alpha-1 antitrypsin (AAT) deficiency (AATD) has been reported. To understand the potential impact on course of inflammation, the aim of...
6.
Lafortune P, Zahid K, Ploszaj M, Awadalla E, Carroll T, Geraghty P
Adv Respir Med
. 2024 Feb;
92(1):1-12.
PMID: 38392031
Alpha-1 antitrypsin (AAT) deficiency (AATD) is an under-recognized hereditary disorder and a significant cause of chronic obstructive pulmonary disease (COPD), a disease that contributes to global mortality. AAT is encoded...
7.
Pillai M, Lafortune P, Dabo A, Yu H, Park S, Taluru H, et al.
ACS Pharmacol Transl Sci
. 2023 Nov;
6(11):1659-1672.
PMID: 37974628
The activity of protein phosphatase 2A (PP2A), a serine-threonine phosphatase, is reduced in the lung fibroblasts of idiopathic pulmonary fibrosis (IPF) patients. The objective of this study was to determine...
8.
Mason E, Menon S, Schneider B, Gaskill C, Dawson M, Moore C, et al.
J Clin Invest
. 2023 Oct;
133(24).
PMID: 37874650
Reactivation and dysregulation of the mTOR signaling pathway are a hallmark of aging and chronic lung disease; however, the impact on microvascular progenitor cells (MVPCs), capillary angiostasis, and tissue homeostasis...
9.
Park S, Mai M, Ploszaj M, Cai H, McGarvey L, Mueller C, et al.
PLoS One
. 2023 Oct;
18(10):e0291948.
PMID: 37819895
Type 1 diabetes (T1D) is a metabolic disease characterized by hyperglycemia and can affect multiple organs, leading to life-threatening complications. Increased prevalence of pulmonary disease is observed in T1D patients,...
10.
Yu H, Zaveri S, Sattar Z, Schaible M, Perez Gandara B, Uddin A, et al.
Medicina (Kaunas)
. 2023 Sep;
59(9).
PMID: 37763671
New disease targets and medicinal chemistry approaches are urgently needed to develop novel therapeutic strategies for treating pulmonary diseases. Emerging evidence suggests that reduced activity of protein phosphatase 2A (PP2A),...